Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin

ClinicalTrials.gov ID: NCT00268853

Public ClinicalTrials.gov record NCT00268853. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 11:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Cyclophosphamide, Doxorubicin, Vincristine, Prednisone Plus Rituximab (CHOP-R) and Cyclophosphamide, Pixantrone, Vincristine, Prednisone Plus Rituximab (CPOP-R) in Patients With Diffuse Large-B-cell Lymphoma: A Phase II, Randomized, Multicenter, Comparative Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the standard CHOP-R regimen of Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Rituximab to CPOP-R (same regimen, but substituting Doxorubicin with Pixantrone). The objective is to show that CPOP-R is not inferior to CHOP-R.

Study identification

NCT ID
NCT00268853
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CTI BioPharma
Industry
Enrollment
124 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2005
Primary completion
Apr 30, 2012
Completion
Apr 30, 2012
Last update posted
May 29, 2024

2005 – 2012

United States locations

U.S. sites
58
U.S. states
27
U.S. cities
54
Facility City State ZIP Site status
Bay Medical Oncology & Hematology Concord California 94520
Hazel Hawkins Hospital, Dept. of Medical Oncology Hollister California 95020
UCSD Moore's Cancer Center-Blood & Marrow Transplantation Division La Jolla California 92093
Loma Linda University Medical Center Loma Linda California 92354
Hematology/Oncology Group of Orange County Orange California 92868
Sharp Memorial Hospital San Diego California 92123
Rocky Mountain Cancer Center Denver Colorado 80218
The Center of Hematology and Oncology Boca Raton Florida 33486
Broward Oncology Associates Fort Lauderdale Florida 33308
Osceola Cancer Center Kissimmee Florida 34741
Watson Clinic for Cancer Care and Research Lakeland Florida 33805
Watson Clinic Lakeland Florida 33805
Memorial Cancer Institute Pembroke Pines Florida 33028
Hematology Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34952
Oncology Hematology Associates of West Broward Tamarac Florida 33321
Hematology Oncology Specialists Tampa Florida 33607
John B. Amos Cancer Center Columbus Georgia 31904
Columbus Clinic Columbus Georgia 39101
Oncology Hematology of Northern Illinois Gurnee Illinois 60031
Mid-Illinois Hematology & Oncology Associates Normal Illinois 61761
Cancer Care Center New Albany Indiana 47150
Consultants in Blood Disorders and Cancer Louisville Kentucky 40207
Western Kentucky Hematology/Oncology Group Paducah Kentucky 42003
Our Lady of the Lake Regional Medial Center, Hematology Oncology Baton Rouge Louisiana 70808
Greater Baltimore Medical Center Baltimore Maryland 21204
Maryland Hematology/Oncology Associates, PA Baltimore Maryland 21237
Center for Cancer and Blood Disorders, P.C. Bethesda Maryland 20817
Frederick Memorial Hospital Cancer Center Frederick Maryland 21701
Tufts-New England Medical Center-The Neely Ctr for Clinical Cancer Research Boston Massachusetts 02111
Hubert H Humphrey Cancer Center Robbinsdale Minnesota 55422
North Missssppi Hematology Oncology Associates Tupelo Mississippi 38801
Capital Comprehensive Cancer Care Jefferson City Missouri 65109
Southeast Nebraska Hematology and Oncology Consultants, P.C. Lincoln Nebraska 68510
Nevada Cancer Institute Las Vegas Nevada 89135
New Mexico Hematology/Oncology Consultants Albuquerque New Mexico 87109
St. Luke's Roosevelt Hospital New York New York 10019
Interlake Foundation, Inc. Rochester New York 14623
Jacobi Medical Center Phase I Oncology The Bronx New York 10461
Our Lady of Mercy Medical Center The Bronx New York 10466
Duke University Medical Center Durham North Carolina 27710
Brody School of Medicine at East Carolina University - Leo W. Jenkins Cancer Center Greenville North Carolina 27858
Cancer Treatment & Research Mid-Dakota Clinic Bismarck North Dakota 58501
Summa Health Systems Hospitals Akron Ohio 44304
Barberton Citizen's Hospital Barberton Ohio 44203
Oncology Partners Network Cincinnati Ohio 45257
Dayton Clinical Oncology Program Dayton Ohio 45429
Northwest Kaiser Permanente Portland Oregon 97227
Berks Hematology-Oncology Associates Ltd. Reading Pennsylvania 19612
Charleston Cancer Center Charleston South Carolina 29406
Low County Hematology & Oncology Mt. Pleasant South Carolina 29464
The Family Cancer Center Collierville Tennessee 38017
Thompson Cancer Survival Center Knoxville Tennessee 37916
Sarah Cannon Cancer Center Nashville Tennessee 37203
Southwest Regional Cancer Center Austin Texas 78705
Texas Hematology Oncology Center Dallas Texas 75234
The Center for Cancer and Blood Disorders Fort Worth Texas 76104
Northern Utah Hematology Oncology, P.C. Ogden Utah 84403
Multicare Oncology Hematology Specialists Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00268853, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 29, 2024 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00268853 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →